30 Apr, EOD - Indian

SENSEX 80242.24 (-0.06)

Nifty 50 24334.2 (-0.01)

Nifty Bank 55087.15 (-0.55)

Nifty IT 35794.95 (-0.35)

Nifty Midcap 100 54124.9 (-0.85)

Nifty Next 50 64508.85 (-0.59)

Nifty Pharma 21772.45 (0.44)

Nifty Smallcap 100 16448.85 (-1.73)

30 Apr, EOD - Global

NIKKEI 225 36452.3 (1.13)

HANG SENG 22119.41 (0.51)

S&P 5649.9 (1.07)

LOGIN HERE

companylogoRajkamal Synthetics Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 514028 | NSE Symbol : | ISIN : INE376L01013 | Industry : Textiles - Processing |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
25-Apr-2025 30-Apr-2025 Accounts Rajkamal Synthetics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve 1. To approve Standalone Audited Financial Results of the Company for the quarter and year ended March 31 2025. 2. Any other business which forms part of the Agenda Paper. Further pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for regulating monitoring and reporting of trading by Insiders and Code of fair disclosure of unpublished price sensitive information the trading window of the Company for the quarter and financial year ended March 31st 2025 is closed from Tuesday April 01 2025 and shall remain close till the expiry of 48 hours after the declaration of Audited Financial Results of the Company for the Quarter and year ended March 31 2025.
07-Feb-2025 13-Feb-2025 Quarterly Results RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday February 13 2025 to consider inter alia: 1. To approve Standalone Unaudited Financial Results with Limited Review of the Company for the quarter and nine months ended December 31 2024. 2. Any other business which forms part of the Agenda Paper Further pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading)Regulations 2015 and the Companys Code of Conduct for regulating monitoring and reporting of trading by Insiders and Code of fair disclosure of unpublished price sensitive information the trading window of the Company for the quarter and nine months ended December 31 2024 is closed from Wednesday January 01 2025 and shall reopen after expiry of 48 hours from declaration of said Financial Results. Unaudited Standalone Financial Results for the Quarter and nine months ended December 31, 2024 (As Per BSE Announcement Dated on: 13/02/2025)
06-Nov-2024 12-Nov-2024 Quarterly Results RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday November 12 2024 to consider inter alia: 1. To approve Standalone Unaudited Financial Results with Limited Review of the Company for the quarter and half year ended September 30 2024. 2. Any other business which forms part of the Agenda Paper. Further pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for regulating monitoring and reporting of trading by Insiders and Code of fair disclosure of unpublished price sensitive information the trading window of the Company for the quarter and half year ended September 30 2024 is closed from Tuesday October 01 2024 and shall reopen after expiry of 48 hours from declaration of said Financial Results. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Tuesday, November 12, 2024, have inter - alia considered and approved the following: 1. Unaudited Standalone Financial Results for the quarter and half ended September 30, 2024 along with Limited Review Report, pursuant to Regulation 33 of the Listing Regulations and other several agenda (As per BSE Announcement Dated on 12/11/2024)
11-Sep-2024 16-Sep-2024 Preferential Issue RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/09/2024 inter alia to consider and approve the proposal for raising of funds by way of a rights issue warrants preferential issue/private placement or through any other permissible mode and/or combination thereof as may be considered appropriate by way of issue of equity shares or any other eligible securities subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company. Outcome of Board Meeting. Preferential Issue of Equity Shares. (As per BSE Announcement Dated on 16/09/2024)
10-Sep-2024 05-Sep-2024 Change in Auditors Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 this is to inform you that Board of Directors of the Company in their Meeting held on Thursday, September 05, 2024 have considered and approved based on recommendation of Audit Committee, appointment of M/s ADV and Associates (FRN - 128045W) as statutory Auditor of the Company for the Financial Year 2024-25 to 2028-29. Further we wish to inform that appointment of statutory auditor was inadvertently missed from our previous outcome announcement mail under Regulation 30 on September 05, 2024. This omission was purely unintentional. We regret any inconvenience this may have caused. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company in their meeting held on Thursday, September 05, 2024 have inter alia considered and approved: based on recommendation of Nomination and Remuneration Committee, appointment of Mr. Atul Kumar Saboo as a Non-Executive Independent Director w.e.f. September 05, 2024 and subject to approval of shareholders of the Company. (As Per Bse Announcement Dated on 05.09.2024)
07-Aug-2024 14-Aug-2024 Quarterly Results RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve To consider and approve the Unaudited standalone Financial Results along with the limited review report for the quarter and three months ended 30th June 2024. b) To consider and approve the proposal for raising of funds by issuance of equity shares / convertible equity warrants convertible bonds / debentures / preference shares / any other equity linked securities and / or any combination thereof (Securities) through permissible modes including through a preferential issue or private placement or qualified institutions placement of the Securities or any other method or mode as may be permitted under applicable laws including the Companies Act 2013 read with the rules notified thereunder and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 and to approve ancillary actions for the above mentioned fund raising subject to such regulatory / statutory approvals as may be required including approval of shareholders in this regard Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''''Listing Regulations''''), we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Wednesday, August 14, 2024, have inter - alia considered and approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2024 along with Limited Review Report, pursuant to Regulation 33 of the Listing Regulations. (As per BSE Announcement Dated on 14/08/2024)
18-Jun-2024 18-Jun-2024 Change in Directors Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company in their meeting held on June 18, 2024 has considered and approved : Based on recommendation of Nomination and Remuneration Committee, appointment of Ms. Mumal Kanwar as an Additional Director in the category of Executive Director w.e.f from June 18, 2024 and subject to approval of shareholders of the Company.
29-Apr-2024 06-May-2024 Accounts RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday May 06 2024 to consider inter alia: 1. To approve Audited Standalone Financials Results of the Company for the quarter and financial year ended March 31 2024. 2. Any other business which form part of the Agenda Paper. Pursuant to SEBI (PIT) Regulations 2015 and the Companys Code of Conduct for regulating monitoring and reporting of the trading by Insiders and Code of fair disclosure of unpublished price sensitive information the trading window of the Company for the quarter and financial year ended shall remain closed from Monday April 01 2024 till the expiry of 48 hours from the date of said Financial Results are made public. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. Monday, May 06, 2024, have inter-alia considered and approved the Audited Standalone Financial Results for the quarter and year ended March 31, 2024 along with Auditor''s Report. Approved Standalone Audited Financial Results for the quarter and year ended March 31, 2024. (As Per BSE Announcement Dated on 06/05/2024) Pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015, we enclose herewith the advertisement published in the newspaper viz:, Financial Express (English) and Mumbai Lakshadeep (Marathi) for the following: Abstract of Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2024. (As Per BSE Announcement Dated on 08/05/2024)
30-Mar-2024 30-Mar-2024 Change in Auditors Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company in its meeting held on Saturday, March 30, 2024 have inter alia considered and approved appointment of M/s Vaibhav Kakkad & Associates, Practicing Company Secretary, as Secretarial Auditor of the Company for the Financial Year 2023-24.
17-Jan-2024 24-Jan-2024 Quarterly Results RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the meeting of Board Of Directors of the Company will be held on Wednesday January 24 2024. 1. To consider and approve unaudited Standalone Financial Results (with Limited Review Report) of the Company for the quarter ended December 31 2023. 2. Any other business which form part of the Agenda Paper. Standalone Unaudited Quarterly Financial Results for the Quarter ended December 31, 2023 along with Limited Review Report by Statutory Auditor is submitted. (As Per BSE Announcement Dated on 24/01/2024)
04-Jan-2024 04-Jan-2024 Others The Board of Directors of the Company in its meeting held on January 04, 2024 has reconstituted all the committees of the Board w.e.f January 04, 2024.
18-Dec-2023 18-Dec-2023 Change in Directors The Company hereby informs that based on the recommendation of NRC the Board of Directors of the Company at its meeting held on December 18, 2023 has considered and approved appointment of Mr. Raj Manishkumar Mehta (DIN-07102601) as an Additional Director in the category of Non Executive Independent Director for the period of 5 years subject to regularisation of appointment by shareholders of the Company at General Meeting. It will also result in re-constitution of Audit, Nomination & Remuneration and Stakeholders Relationship Committee by appointment of Mr. Raj Manishkumar Mehta
26-Oct-2023 01-Nov-2023 Quarterly Results RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the meeting of the Board of Directors of the Company is scheduled to be held on November 1 2023 . 1. To consider and approve Unaudited Standalone Financial result (with limited review) of the Company for quarter ended September 30 2023. 2. Any other business which forms part of the agenda paper. Unaudited Standalone Financial Results - for the quarter and half year ended September 30, 2023 with limited review report This is to inform you that the Board of Directors of the Company in its meeting held today viz. Wednesday, November 1, 2023 which commenced at 4:50 P.M and concluded at 5:35 P.M have considered and approved following business 1. Approved the standalone Unaudited Standalone Financial Results(with Limited Review Report) of the Company for the quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 01/11/2023)
14-Oct-2023 14-Oct-2023 Change in Auditors Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and read with SEBI Circular, we wish to inform that based on the recommendation of the Audit Committee, the Board of Directors at their meeting held today i.e. October 14, 2023, subject to shareholders approval of the Company, has appointed M/s. ADV & Associates, Chartered Accountant (ICAI Firm Registration: 128045W) as statutory auditor of the Company to fill the casual vacancy.
22-Aug-2023 22-Aug-2023 Change in Directors Pursuant to Regulation 30 SEBI (LODR)Regulations, 2015 this is to inform you that the Board of Directors of the Company in their meeting held on Tuesday, August 22, 2023 has considered and approved appointment of M/s Vaibhav Kakkad & Associates to issue Secretarial Audit Report of the Company for the financial year 2022-23. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 this is to inform you that the Board of Directors of the Company in their meeting held on Tuesday, August 22, 2023 has considered and approved appointment of Ms. Seema Kothari (DIN-10087089) as an Additional Director in the category of Executive Director, subject to approval of members of the Company.
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +